0001567619-21-020653.txt : 20211117
0001567619-21-020653.hdr.sgml : 20211117
20211117161544
ACCESSION NUMBER: 0001567619-21-020653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Newell Joe
CENTRAL INDEX KEY: 0001702457
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 211420794
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 611 GATEWAY BOULEVARD, SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2021-11-15
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001702457
Newell Joe
C/O ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Operations Officer
Common Stock
2021-11-15
4
M
0
3500
12.15
A
123429
D
Common Stock
2021-11-15
4
S
0
7000
17.7149
D
116429
D
Employee Stock Option (Right to Buy)
12.15
2021-11-15
4
M
0
2792
0
D
2030-02-28
Common Stock
2792
32083
D
Employee Stock Option (Right to Buy)
12.15
2021-11-15
4
M
0
708
0
D
2030-02-28
Common Stock
708
9917
D
Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.62 to $17.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
/s/ David Tucker, Attorney-in-Fact for Joe Newell
2021-11-17